Press releases

Revacept is a novel platelet inhibitor that binds specifically to injured blood vessels and can be used safely during catheter interventions. This is now demonstrated in a study enrolling patients with narrowed coronary arteries co-funded by the German Centre for Cardiovascular...

Read more

Recovering from a corona infection at home - that's what most people want to do. But sometimes hospitalization is unavoidable. But when is the right time for this? This is being investigated by the COVID SMART study at LMU Klinikum München. Anyone who has risk factors for a...

Read more

A small, wearable heart monitor can detect atrial fibrillation in high-risk patients ten times more frequently than standard tests. This is the result of a new trans-Atlantic study involving researchers from Canada and Germany.

Read more

Cardiac arrhythmias were the most common cardiovascular problem in hospitalized COVID-19 patients. This is shown in an evaluation by scientists of the German Centre for Cardiovascular Research (DZHK) at the Department of Cardiology, Angiology and Pneumology at Heidelberg...

Read more

For the first time, engineered heart muscle (EHM) from human induced pluripotent stem cells (iPSCs) will be used to treat patients with heart failure. After regulatory approval, recruitment of the first patient for the first-in-class, first-in-patient BioVAT-HF-DZHK20 early...

Read more

Diastolic heart failure can be reliably detected with a newly developed magnetic resonance imaging (MRI) technology, shows a study by the German Centre for Cardiovascular Research (DZHK) at the Göttingen site. Until now, this was only possible with a heart catheterisation study,...

Read more

Circulatory disorders in the heart can have two causes: The large blood vessels can be narrowed, which can be treated with a stent, for example, or the small, finely branched vessels are no longer permeable. The latter is called impaired coronary microcirculation. A study by the...

Read more

After an infection, the risk of a heart attack in cardiovascular risk patients increases up to twenty times. Scientists from the German Centre for Cardiovascular Research (DZHK) have found that the immune cells are involved in this in a mouse model. However, specific molecules...

Read more

To protect against sudden cardiac death, all patients with severe cardiac insufficiency, in which the heart's pumping capacity is highly restricted, are currently implanted with a defibrillator. But the procedure is risky and often unnecessary. Every year, the device triggers a...

Read more

In laboratory models, the coronavirus can directly infect heart muscle cells, a team from several working groups at the German Centre for Cardiovascular Research (DZHK) found out. However, the virus uses a slightly different mechanism than in lung cells. If a direct infection of...

Read more